Interleukin 1 Receptor Antagonist (IL-1Ra) is an Acute-phase Protein

Overview

Journal J Clin Invest

Specialty General Medicine

Date 1997 Jun 15

PMID 9185517

Citations 86

Authors

C Gabay

M F Smith

D Eidlen

W P Arend

Affiliations

Soon will be listed here.

Abstract

Interleukin 1 receptor antagonist (IL-1Ra) levels are elevated in the blood of patients with a variety of infectious, immune, or traumatic conditions. To examine whether IL1Ra is produced by liver cells with characteristics resembling an acute-phase protein, human primary hepatocytes isolated from liver biopsies and HepG2 hepatoma cells were stimulated with IL-1beta, IL-6, and TNFalpha. IL-1Ra was present in the supernatants of both cells, with production significantly enhanced by IL-1beta, and by the combination of IL-1beta and IL-6. The term IL-1Ra refers to two different proteins encoded by the same gene, but generated by alternative splicing of two different first exons. One isoform is secreted (17-kD sIL-1Ra), and the other isoform remains in the cytoplasm (18-kD icIL-1Ra). By Western blot analysis, the supernatants of human hepatoma (HepG2) cells contained only sIL-1Ra, whereas the lysates contained a novel smaller molecular mass isoform of 16 kD. RT-PCR and ribonuclease protection assay with RNA from HepG2 cells showed that only sIL-1Ra mRNA was expressed, and confirmed the inducing effect of IL-1beta and IL-6. Transfection studies were performed using constructs containing the promoters of either sIL-1Ra or icIL-1Ra coupled to the luciferase reporter gene. The sIL-1Ra promoter was active in HepG2 cells stimulated by IL-1beta and/or IL-6, whereas the icIL-1Ra promoter was inactive. Mutation of binding sites for transcription factors NF-kappaB and/or C/EBP within the proximal sIL-1Ra promoter led to significant decreases in response to IL-1beta and IL-6 in comparison to the wild-type promoter. Electromobility gel shift assays confirmed the presence of NF-kappaB and C/EBP binding sites within the sIL-1Ra promoter, and indicated a significant increase in the binding activities of nuclear proteins from HepG2 cells treated with IL-1beta and IL-6. In summary, sIL-1Ra, but not icIL-1Ra, is produced by hepatocytes, and is regulated by proinflammatory cytokines as an acute-phase protein. In addition, NF-kappaB and C/EBP family members are likely to play important roles in the full expression of IL-1Ra by hepatocytes during inflammatory conditions.

Citing Articles

Host Genetic Impact on Infectious Diseases among Different Ethnic Groups.

Naidoo L, Arumugam T, Ramsuran V Adv Genet (Hoboken). 2023; 4(4):2300181.

PMID: 38099246 PMC: 10716055. DOI: 10.1002/ggn2.202300181.

Conflicts hurt: social stress predicts elevated pain and sadness after mild inflammatory increases.

Madison A, Renna M, Andridge R, Peng J, Shrout M, Sheridan J Pain. 2023; 164(9):1985-1994.

PMID: 36943254 PMC: 10440304. DOI: 10.1097/j.pain.0000000000002894.

Humoral Innate Immunity and Acute-Phase Proteins.

Mantovani A, Garlanda C N Engl J Med. 2023; 388(5):439-452.

PMID: 36724330 PMC: 9912245. DOI: 10.1056/NEJMra2206346.

Understanding Ocular Surface Inflammation in Tears Before and After Autologous Cultivated Limbal Epithelial Stem Cell Transplantation.

Figueiredo G, Hogg J, Okonkwo A, Baylis O, Berry M, Ali S Ophthalmol Ther. 2023; 12(2):1097-1107.

PMID: 36708444 PMC: 10011244. DOI: 10.1007/s40123-023-00656-6.

The Effects of 21-Day General Rehabilitation after Hip or Knee Surgical Implantation on Plasma Levels of Selected Interleukins, VEGF, TNF-α, PDGF-BB, and Eotaxin-1.

Idzik M, Poloczek J, Skrzep-Poloczek B, Drozdz E, Chelmecka E, Czuba Z Biomolecules. 2022; 12(5).

PMID: 35625533 PMC: 9139046. DOI: 10.3390/biom12050605.

References

Seglen P . Preparation of isolated rat liver cells. Methods Cell Biol. 1976; 13:29-83. DOI: 10.1016/s0091-679x(08)61797-5. View

Lai C, Baumann H . Interleukin-1 beta induces production of granulocyte colony-stimulating factor in human hepatoma cells. Blood. 1996; 87(10):4143-8. View

Chirgwin J, Przybyla A, MacDonald R, Rutter W . Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 1979; 18(24):5294-9. DOI: 10.1021/bi00591a005. View

Kushner I . The phenomenon of the acute phase response. Ann N Y Acad Sci. 1982; 389:39-48. DOI: 10.1111/j.1749-6632.1982.tb22124.x. View

Dignam J, Lebovitz R, Roeder R . Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 1983; 11(5):1475-89. PMC: 325809. DOI: 10.1093/nar/11.5.1475. View

Prieur A, KAUFMANN M, Griscelli C, Dayer J . Specific interleukin-1 inhibitor in serum and urine of children with systemic juvenile chronic arthritis. Lancet. 1987; 2(8570):1240-2. DOI: 10.1016/s0140-6736(87)91854-x. View

Castell J, Gomez-Lechon M, David M, Andus T, Geiger T, Trullenque R . Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Lett. 1989; 242(2):237-9. DOI: 10.1016/0014-5793(89)80476-4. View

Osborn L, Kunkel S, Nabel G . Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc Natl Acad Sci U S A. 1989; 86(7):2336-40. PMC: 286907. DOI: 10.1073/pnas.86.7.2336. View

Baumann H, Prowse K, Marinkovic S, Won K, Jahreis G . Stimulation of hepatic acute phase response by cytokines and glucocorticoids. Ann N Y Acad Sci. 1989; 557:280-95, discussion 295-6. DOI: 10.1111/j.1749-6632.1989.tb24021.x. View

10.

Baumann H, Wong G . Hepatocyte-stimulating factor III shares structural and functional identity with leukemia-inhibitory factor. J Immunol. 1989; 143(4):1163-7. View

11.

Hannum C, Wilcox C, Arend W, Joslin F, Dripps D, Heimdal P . Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature. 1990; 343(6256):336-40. DOI: 10.1038/343336a0. View

12.

Heinrich P, Castell J, Andus T . Interleukin-6 and the acute phase response. Biochem J. 1990; 265(3):621-36. PMC: 1133681. DOI: 10.1042/bj2650621. View

13.

Baumann H, Gauldie J . Regulation of hepatic acute phase plasma protein genes by hepatocyte stimulating factors and other mediators of inflammation. Mol Biol Med. 1990; 7(2):147-59. View

14.

Akira S, Isshiki H, Sugita T, TANABE O, Kinoshita S, Nishio Y . A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J. 1990; 9(6):1897-906. PMC: 551896. DOI: 10.1002/j.1460-2075.1990.tb08316.x. View

15.

Cominelli F, Nast C, Clark B, Schindler R, Lierena R, Eysselein V . Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis. J Clin Invest. 1990; 86(3):972-80. PMC: 296817. DOI: 10.1172/JCI114799. View

16.

Haskill S, Martin G, Van Le L, Morris J, Peace A, Bigler C . cDNA cloning of an intracellular form of the human interleukin 1 receptor antagonist associated with epithelium. Proc Natl Acad Sci U S A. 1991; 88(9):3681-5. PMC: 51516. DOI: 10.1073/pnas.88.9.3681. View

17.

Dripps D, Brandhuber B, Thompson R, Eisenberg S . Interleukin-1 (IL-1) receptor antagonist binds to the 80-kDa IL-1 receptor but does not initiate IL-1 signal transduction. J Biol Chem. 1991; 266(16):10331-6. View

18.

Granowitz E, Clark B, Mancilla J, Dinarello C . Interleukin-1 receptor antagonist competitively inhibits the binding of interleukin-1 to the type II interleukin-1 receptor. J Biol Chem. 1991; 266(22):14147-50. View

19.

Ganapathi M, Rzewnicki D, Samols D, Jiang S, Kushner I . Effect of combinations of cytokines and hormones on synthesis of serum amyloid A and C-reactive protein in Hep 3B cells. J Immunol. 1991; 147(4):1261-5. View

20.

Baumann H, Schendel P . Interleukin-11 regulates the hepatic expression of the same plasma protein genes as interleukin-6. J Biol Chem. 1991; 266(30):20424-7. View